SEC Company Response from MESOBLAST (MESO) — Jan 12, 2026
MESOBLAST LTD
Date: Jan. 12, 2026 · CIK: 0001345099 · Accession: 0001213900-26-003200
AI Filing Summary & Sentiment
File numbers found in text: 333-292498
Show Raw Text
CORRESP 1 filename1.htm Mesoblast Limited Level 38, 55 Collins Street Melbourne, VIC 3000 Australia January 12, 2026 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 via EDGAR RE: Mesoblast Limited Registration Statement on Form F-3 Filed: December 30, 2025 Securities Act File No.: 333-292498 Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, Mesoblast Limited (the "Registrant") hereby respectfully requests acceleration of its Registration Statement on Form F-3 (File No. 333-292498), initially filed on December 30, 2025, so that it will become effective at 9:00 a.m. (Eastern time) on January 14, 2026, or as soon as practicable thereafter. If you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant's outside counsel, at andrew.reilly@rimonlaw.com. The Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the "Commission") declares the filing effective, such action: (i) does not foreclose the Commission from taking any action with respect to the filing; (ii) does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) may not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, Mesoblast Limited By: /s/ Andrew Chaponnel Andrew Chaponnel Head of Finance